Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: Results after 5 years

Vaccine

Volumn 16, Issue 2-3, 1998, Pages 232-235

  Fan, Pi Chuan ^a   Chang, Mei Hwei ^a   Lee, Ping Ing ^a   Safary, A ^b   Lee, Chin Yun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Children; Hepatitis A virus vaccine; Long term immunogenicity

Indexed keywords

HEPATITIS A VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TAIWAN; VACCINATION;

CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; SEX FACTORS; TAIWAN; TIME FACTORS; VACCINES, INACTIVATED; VIRAL HEPATITIS VACCINES;

EID: 0031986247     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00179-5     Document Type: Article

References (20)

1. 1 Hadler, S.C., Global pattern of hepatitis A virus infection changing patterns. In Viral Hepatitis and Liver Disease, ed. F.B., Hollinger, S.M. Lemon and H. Margolis, Williams and Wilkins, Baltimore, 1991, pp. 14-20.
2. 2 Midthun, K., Ellerbeck, E. and Gershman, K. et al. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. Journal of Infectious Diseases 1991, 163, 735-739.
3. 3 Yao, G., Clinical spectrum and natural history of viral hepatitis A in the 1988 Shanghai epidemic. In Viral Hepatitis and Liver Disease, ed. F.B. Hollinger, S.M. Lemon and H. Margolis, Williams and Wilkins, Baltimore, 1991, pp. 76-78.
4. 4 Hsu, H.Y., Chang, M.H., Chen, D.S., Lee, C.Y. and Sung, J.L. Changing seroepidemiology of hepatitis A virus infection in Taiwan. Journal of Medical Virology 1985, 17, 297-301.
5. 5 Tzen, K.T., Chang, M.H., Tsen, Y.J., Lee, C.Y. and Chen, D.S. Hepatitis A virus infection in Taipei city in 1989. Journal of the Formosan Medical Association 1991, 90, 138-140.
6. 6 Shapiro, C.N. and Margolis, H.S. Worldwide epidemiology of hepatitis A virus infection. Journal of Hepatology 1993, 18, S11-S14.
7. 7 Wu, J.S., Lu, C.F. and Wu, L.Z. et al. Changing seroepidemiology of hepatitis A virus infection between two regions in Taiwan differing in socioeconomic status. Journal of the Formosan Medical Association 1993, 92, 812-815.
8. 8 Innis, B.L., Snitbhan, R. and Kunasol, P. et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994, 271, 1328-1334.
9. 9 Horng, Y.C., Chang, M.H. and Lee, C.Y. et al. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatric Infectious Diseases Journal 1993, 12, 359-362.
10. 10 Lee, W.T., Chang, M.H. and Chen, D.S. et al. Follow-up immunogenicity of an inactivated hepatitis A vaccine in healthy children: result after two years. Acta Paediatrica Sinica 1995, 36, 331-335.
11. 11 Karpinski, K.F., Hayard, S. and Tryphonas, H. Statistical consideration in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA). Journal of Immunological Methods 1987, 103, 189-194.
12. 12 Wiedermann, G., Ambrosch, F. and Andre, F.E. et al. Persistence of vaccine-induced antibody to hepatitis A virus. Vaccine 1992, 10, S129-S131.
13. 13 Van Damme, P., Thoelen, S. and Cramm, M. et al. Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long-term antibody persistence. Journal of Medical Virology 1994, 44, 446-451.
14. 14 Lee, S.D., Lo, K.J. and Chan, C.Y. et al. Immunogenocity of inactivated hepatitis A vaccine in children. Gastroenterology 1993, 104, 1129-1132.
15. 15 Tabor, E., Clinical presentation of hepatitis A. In Hepatitis A, ed. R.J. Gerety, Academic Press, Orlando, FL, 1984, pp. 47-53.
16. 16 Kane, M. Prospects for the introduction of hepatitis A vaccine into public health use. Progress in Medical Virology 1990, 37, 96-100.
17. 17 Green, M.S., Shohat, T. and Lerman, Y. et al. Sex differences in the humoral antibody response to live measles vaccine in young adults. International Journal of Epidemiology 1994, 23, 1078-1081.
18. 18 Hollinger, F.B., Adam, E., Heiberg, D. et al., Response to hepatitis B vaccine in a young adult population. In Viral Hepatitis, ed. W. Szmuness, H.J. Alter and J.E. Maynard, Franklin Institute Press, Philadelphia, PA, 1981, pp. 451-466.
19. 19 Mitchell, L.A., Zhang, T. and Tingle, A.J. Differential antibody responses to rubella virus infection in males and females. Journal of Infectious Diseases 1992, 166, 1258-1265.
20. 20 Rhodes, K., Markham, R.L. and Maxwell, P.M. et al. Immunoglobulins and the X-chromosome. British Medical Journal 1969, 3, 439-441.